SCHEDULE 13G/A: BlackRock Discloses 7.1% Passive Stake in Atea Pharmaceuticals
Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% beneficial ownership stake in Atea Pharmaceuticals, Inc. as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 6,082,350 shares of Atea Pharmaceuticals, Inc. common stock.
- This ownership represents 7.1% of Atea Pharmaceuticals, Inc.'s outstanding common stock.
- BlackRock holds sole voting power over 5,982,716 shares and sole dispositive power over all 6,082,350 shares.
- The filing is an Amendment No. 4 to a Schedule 13G, indicating a passive investment position.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine ownership disclosure filing and does not contain performance or forward-looking statements.
Future Outlook
NA
Industry Context
This filing is a routine disclosure by a large institutional investor, BlackRock, Inc., regarding its passive ownership stake in Atea Pharmaceuticals, Inc. It reflects standard portfolio management activities rather than a strategic industry move or a change in Atea's operational landscape.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's passive stake, confirming BlackRock's continued investment in Atea Pharmaceuticals.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney date, which was revoked by the new one. |
| 2025-01-21 | Effective date of the new Power of Attorney for BlackRock, Inc. |
| 2025-03-31 | Date of event which requires the filing of this statement (reporting period end). |
| 2025-04-23 | Signature date of the Schedule 13G filing. |
Keywords
BlackRock, Atea Pharmaceuticals, Schedule 13G, Ownership Disclosure, Institutional Investor, Common Stock, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.